Good. See how things go when production, if it ever happens, doesn't cover expenses, and they do another C.R. at .4 > .3 cents.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025